Pneumonia death rate lower among people who take statins

Apr 05, 2011

Taking statins could help prevent people dying from pneumonia, according to a study by the London School of Hygiene and Tropical Medicine.

The researchers found that the risk of death in the six month period after diagnosis of pneumonia was substantially lower among those who were already receiving the cholesterol-lowering drugs compared with those who were not.

Previous studies have suggested that statins may be associated with a more favourable outcome after .

This study, published online in the BMJ today, supports a possible protective effect of statins against mortality in patients with pneumonia.

But the researchers point out that as they looked at patients who were already taking the medication when they developed pneumonia, a randomised clinical trial is needed to determine whether starting a statin at the time of diagnosis has a similar effect

Funded by the Wellcome Trust and the Medical Research Council, the team of epidemiologists used data from The Health Improvement Network (THIN), a database of computerised medical records of doctors' practices in the UK, to identify statin users for the study.

They matched each statin user, who were aged over 40 at first prescription of a statin between 1995 and 2006, with up to five non-statin users.

Patients with a record of pneumonia were followed for six months to see if they died and the scientists found that 13% (109 out of 847) of statin users died compared with 20% (578 out of 2927) of non-statin users.

While the study tried to minimise confounding variables, the researchers point out that they cannot rule out the possibility that unknown differences between users and non-users could have contributed to the results.

Lead author Dr Ian Douglas, lecturer in epidemiology at LSHTM, said: "Statins are safe, cheap, and an easy intervention in terms of delivery.

"Given the potential low number needed to treat to prevent a death suggested by this study, we believe that a strong case exists for randomised trials of statins in people with serious infection to determine if a simple and practical intervention at the point of diagnosis of has a beneficial effect."

Explore further: Breaking bad mitochondria: Mechanism helps explain persistence of hepatitis C virus

Provided by London School of Hygiene & Tropical Medicine

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Statins associated with lower risk of death from pneumonia

Oct 27, 2008

Individuals who take cholesterol-lowering statins before being hospitalized with pneumonia appear less likely to die within 90 days afterward, according to a report in the October 27 issue of Archives of Internal Medicine, one of ...

Recommended for you

Thyroid disease risk varies among blacks, Asians, and whites

15 hours ago

An analysis that included active military personnel finds that the rate of the thyroid disorder Graves disease is more common among blacks and Asian/Pacific Islanders compared with whites, according to a study in the April ...

The key to easy asthma diagnosis is in the blood

18 hours ago

Using just a single drop of blood, a team of University of Wisconsin-Madison researchers has developed a faster, cheaper and more accurate tool for diagnosing even mild cases of asthma.

User comments : 0

More news stories

What are the chances that your dad isn't your dad?

How confident are you that the man you call dad is really your biological father? If you believe some of the most commonly-quoted figures, you could be forgiven for not being very confident at all. But how ...

Making 'bucky-balls' in spin-out's sights

(Phys.org) —A new Oxford spin-out firm is targeting the difficult challenge of manufacturing fullerenes, known as 'bucky-balls' because of their spherical shape, a type of carbon nanomaterial which, like ...

Gene removal could have implications beyond plant science

(Phys.org) —For thousands of years humans have been tinkering with plant genetics, even when they didn't realize that is what they were doing, in an effort to make stronger, healthier crops that endured climates better, ...